Sema3A relieves neuropathic pain by reducing eIF2α phosphorylation via suppressing PI3K/Akt/mTOR pathway

Area of Science:

• Neuroscience
• Molecular Biology
• Pain Research

Background:

• Primary sensory neurons link the peripheral and central nervous systems, transmitting pain signals.
• Peripheral nerve injury can lead to nerve fiber regeneration and severe neuropathic pain.
• Semaphorin3A (Sema3A) inhibits nerve regeneration but its role in neuropathic pain is unclear.

Purpose of the Study:

• To investigate the role of Sema3A in neuropathic pain.
• To explore the underlying molecular mechanisms of Sema3A's action in pain.
• To identify potential therapeutic targets for neuropathic pain relief.

Main Methods:

• A chronic constriction injury (CCI) mouse model of neuropathic pain was utilized.
• Sema3A was overexpressed in dorsal root ganglion (DRG) neurons via injection.
• The PI3K/Akt/mTOR signaling pathway and eIF2α phosphorylation were analyzed.
• PKR and PERK inhibitors were used to assess the impact on ion channel expression.

Main Results:

• Increased Sema3A expression alleviated mechanical and heat nociceptive behaviors in CCI mice.
• Sema3A overexpression inhibited PI3K/Akt/mTOR pathway and eIF2α phosphorylation in DRG neurons.
• Inhibition of eIF2α phosphorylation reduced ion channel expression and neuropathic pain.
• Sema3A suppressed eIF2α phosphorylation by inhibiting the PI3K/AKT/mTOR pathway.

Conclusions:

• Decreased Sema3A expression in DRG neurons is associated with peripheral nerve injury.
• Elevating Sema3A levels alleviates neuropathic pain by modulating the PI3K/Akt/mTOR pathway and eIF2α phosphorylation.
• Sema3A and eIF2α phosphorylation represent potential therapeutic targets for neuropathic pain management.